Enzo Biochem Inc
ENZBDelisted Apr 7, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000316253
Enzo Biochem Inc was delisted on Apr 7, 2025; its insiders filed their last Form 4 on Aug 20, 2025; 41 institutions reported holding it in 13F filings for Q1 2025, worth $4.96M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Enzo Biochem Inc as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −7 vs. Q2 2023
- Shares held
- 16.5M
- −2.30M (−12.2%) vs. Q2 2023
- Total value
- $23.1M
- −$11.5M (−33.2%) vs. Q2 2023
- New holders
- 4
- 7 more added
- Sold out
- 11
- 9 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENZB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 7 | $2.00M |
| Q1 2025 | 41 | $4.96M |
| Q4 2024 | 44 | $9.71M |
| Q3 2024 | 43 | $14.2M |
| Q2 2024 | 39 | $13.5M |
| Q1 2024 | 41 | $17.6M |
| Q4 2023 | 46 | $22.7M |
| Q3 2023 | 39 | $23.1M |
| Q2 2023 | 47 | $34.7M |
| Q1 2023 | 52 | $48.1M |
| Q4 2022 | 52 | $26.8M |
| Q3 2022 | 49 | $45.6M |
| Q2 2022 | 54 | $43.8M |
| Q1 2022 | 51 | $62.0M |
| Q4 2021 | 59 | $69.0M |
| Q3 2021 | 65 | $82.9M |
| Q2 2021 | 72 | $76.6M |
| Q1 2021 | 82 | $94.6M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Enzo Biochem Inc; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Harbert Fund Advisors, Inc. | 5,175,913 | $7.25M | 5.17% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 2,556,064 | $3.58M | 0.01% | −148,800−5.5% | Reduced |
| Tang Capital Management LLC | 2,200,000 | $3.08M | 0.43% | −100,000−4.3% | Reduced |
| Vanguard Group Inc | 1,729,084 | $2.42M | 0.00% | 00.0% | Unchanged |
| Potomac Capital Management, Inc. | 1,455,000 | $2.04M | 2.62% | +405,100+38.6% | Added |
| BlackRock Inc. | 955,394 | $1.34M | 0.00% | −43,085−4.3% | Reduced |
| Dimensional Fund Advisors LP | 843,086 | $1.18M | 0.00% | −423,989−33.5% | Reduced |
| Geode Capital Management, LLC | 337,856 | $473.1K | 0.00% | +281+0.1% | Added |
| RBF Capital, LLC | 250,359 | $350.5K | 0.02% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 227,100 | $317.9K | 0.01% | −82,299−26.6% | Reduced |
| State Street Corp | 167,039 | $233.9K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 104,181 | $145.9K | 0.00% | −399−0.4% | Reduced |
| Assenagon Asset Management S.A. | 81,197 | $113.7K | 0.00% | −100,665−55.4% | Reduced |
| Morgan Stanley | 75,639 | $105.9K | 0.00% | +8,000+11.8% | Added |
| Shay Capital LLC | 62,500 | $87.5K | 0.03% | +62,500 | New |
| Lazard Asset Management LLC | 50,453 | $70.0K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 44,800 | $63.0K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 26,217 | $36.7K | 0.00% | 00.0% | Unchanged |
| Kempner Capital Management Inc. | 25,475 | $36.0K | 0.02% | 00.0% | Unchanged |
| Sage Mountain Advisors LLC | 23,362 | $32.7K | 0.00% | 00.0% | Unchanged |
| Snowden Capital Advisors LLC | 21,499 | $30.1K | 0.00% | −1,200−5.3% | Reduced |
| AE Wealth Management LLC | 20,000 | $28.0K | 0.00% | 00.0% | Unchanged |
| Paradigm Financial Partners, LLC | 19,500 | $26.3K | 0.01% | 00.0% | Unchanged |
| Raymond James Trust N.A. | 17,016 | $23.8K | 0.00% | 00.0% | Unchanged |
| Shulman DeMeo Asset Management LLC | 15,487 | $21.7K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 15,453 | $21.6K | 0.00% | +5,544+55.9% | Added |
| Charles Schwab Investment Management Inc | 13,471 | $18.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 7,334 | $10.3K | 0.00% | +1,288+21.3% | Added |
| Covestor Ltd | 3,967 | $6.00K | 0.00% | +3,967 | New |
| Bank of America Corp | 3,088 | $4.32K | 0.00% | 00.0% | Unchanged |
| NBC Securities, Inc. | 2,525 | $3.00K | 0.00% | +2,525 | New |
| JPMorgan Chase & Co | 1,833 | $2.57K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,731 | $2.42K | 0.00% | +728+72.6% | Added |
| Wells Fargo & Company | 1,282 | $1.80K | 0.00% | +7+0.5% | Added |
| Royal Bank of Canada | 1,085 | $1.00K | 0.00% | −97−8.2% | Reduced |
| FMR LLC | 300 | $420 | 0.00% | +300 | New |
| Focused Wealth Management, Inc | 110 | $154 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 10 | $14 | 0.00% | 00.0% | Unchanged |
| Benjamin Edwards Inc | 300 | $0 | 0.00% | 00.0% | Unchanged |
| Fuller & Thaler Asset Management, Inc. | 0 | $0 | 0.00% | −985,660−100.0% | Sold out |
| Roumell Asset Management, LLC | 0 | $0 | 0.00% | −681,358−100.0% | Sold out |
| Fifth Lane Capital, LP | 0 | $0 | 0.00% | −85,000−100.0% | Sold out |
| Corsair Capital Management, L.P. | 0 | $0 | 0.00% | −47,726−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −19,610−100.0% | Sold out |
| Agate Pass Investment Management, LLC | 0 | $0 | 0.00% | −16,292−100.0% | Sold out |
| Cutter & CO Brokerage, Inc. | 0 | $0 | 0.00% | −15,500−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −11,534−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −11,705−100.0% | Sold out |
| Wealth Alliance | 0 | $0 | 0.00% | −11,033−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −619−100.0% | Sold out |
| BDO Wealth Advisors, LLC | – | – | – | – | Not filed |